Find information on drug development, applications, submissions, manufacturing & quality, safety, labeling and more
Similar Posts
FDA/MHRA/Health Canada Symposium: Regulatory perspectives in good clinical practice, bioequivalence and good pharmacovigilance practice – 06/02/2026
This symposium will highlight current and emerging topics of interest to the industry related to good clinical practice, bioequivalence and good pharmacovigilance practice.Green Lumber Holding, LLC Issues Consumer Alert on Counterfeit Products Following FDA Findings
Costa Mesa, California August 28, 2025 – Green Lumber Holding, LLC (“Green Lumber”) is alerting consumers that counterfeit products misrepresented as genuine Green Lumber have been identified and may pose health risks.Report on the State of Pharmaceutical Quality
The mission of the Office of Pharmaceutical Quality is to assure that quality medicines are available to the American public. The annual Report on the State of Pharmaceutical Quality is intended to help characterize the quality of the U.S. drug supply chain. Learn more.Resources for Biomarker Requestors
Information and resources for requestors about FDA’s Biomarker Qualification ProgramEssential Pharmacy Compounding, Omaha, NE., 483 Issued 05/22/2015
Task Description Request Please post to the 2015 Pharmacy Inspections and Related Records page.
Record Date 05/22/2015
FEI Number 3003718003
Firm Name Essential Pharmacy Compounding
Record Type 483
State NE
Establishment Type Producer of Sterile Drug Products